LATEST
GTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire StockbridgeProofpoint agreed to acquire VaronisPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 2 Mar 2026

Rallybio /
Candid Therapeutics, Inc.

Rallybio agrees to buy Candid Therapeutics, Inc.

Buy side: Rallybio
Buy sideRallybio
Target: Candid Therapeutics, Inc.
TargetCandid Therapeutics, Inc.
Rallybio · 2 Mar 2026Source
See the source
Buy side: Rallybio
Buy sideRallybio
Target: Candid Therapeutics, Inc.
TargetCandid Therapeutics, Inc.
01 / BuyerRallybio
02 / TargetCandid Therapeutics, Inc.
Source for the buyer and target: Rallybio

For the buyer and target.

“On March 1, 2026, Rallybio Corporation, a Delaware corporation (“ Rallybio ”), entered into an Agreement and Plan of Merger and Reorganization (the “ Merger Agreement ”) with Candid Therapeutics, Inc., a Delaware corporation (“ Candid ”), a clinical-stage biotechnology company advancing a leading portfolio of T-cell engager (TCE) therapeutics for autoimmune diseases, and Farmington Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Rallybio (“ Merger Sub ”).”

Published 2 Mar 2026

Open the source
01

What happened

Rallybio agreed to acquire Candid Therapeutics, Inc., according to a filing dated March 2, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Rallybio

Rallybio agrees to buy Candid Therapeutics, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “Rallybio agrees to buy Candid Therapeutics, Inc. Rallybio agreed to acquire Candid Therapeutics, Inc., according to a filing dated March 2, 2026”

    Open the source

  2. Published by Rallybio

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.